Drug Database
Back to search

United States· US:54766-895_557ed953-bb9c-8e24-e063-6394a90a525f

LOTRONEX

A alosetron product containing alosetron hydrochloride, registered in United States by Sebela Pharmaceuticals Inc..

ATC A03AE01

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedLOTRONEXATCA03AE01REGISTER NO.US:54766-895_557ed953…PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about alosetron hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ALOSETRON HYDROCHLORIDE
Manufacturer
Sebela Pharmaceuticals Inc.
Country
United States (US)
ATC code
A03AE01
ATC class
Alosetron
Defined daily dose
1 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    54766-895-03

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

156 interactions on record for alosetron.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check alosetron against other medicinesHow interaction checks work

Alosetron · interactions on record

156 records

  • 4 severe
  • 64 moderate
  • 2 minor
  • 86 info

Most severe, free to view

  • ApomorphineG04BE07severe
  • ApomorphineN04BC07severe
  • FluvoxamineN06AB08severe
  • ApomorphinV03AB45severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under A03AE01

Alosetron, as other registers publish it.

All alosetron products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c93d80de-0d90-484c-99e7-343d54e0be31
GET /v1/drugs/c93d80de-0d90-484c-99e7-343d54e0be31?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "1",
  "substance": "ALOSETRON HYDROCHLORIDE",
  "productndc": "54766-895",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA021107",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about alosetron.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console